Background-Diastolic dysfunction is a major pathophysiological abnormality in hypertrophic cardiomyopathy (HCM).
D iastolic dysfunction is a major contributor to the underlying pathophysiology in patients with hypertrophic cardiomyopathy (HCM). 1 Diastolic dysfunction is the sum total of a complex sequence of multiple interrelated events, including prolonged ventricular relaxation, loss of ventricular suction, increased myocardial fibrosis, and increased chamber stiffness, that result in symptoms of angina and dyspnea. In the past, cardiac catheterization was required to determine the extent of diastolic dysfunction by direct measurement of left ventricular (LV) filling pressures. The development of noninvasive Doppler indices including transmitral flow velocities and tissue Doppler imaging (TDI) has allowed noninvasive estimation of filling pressures in patient populations other than HCM. [2] [3] [4] However, studies that have attempted to correlate filling pressures with these noninvasive indices in HCM have led to mixed results. [5] [6] [7] [8] [9] [10] The objective of this study was to examine the clinical utility of currently available Doppler echocardiographic measurements in the assessment of LV filling pressures in HCM, with correlation of direct measures of left atrial pressure (LAP) at cardiac catheterization.
LAP. The diagnosis of HCM was based on the presence of myocardial hypertrophy in the absence of local or systemic etiologies. [11] [12] [13] Patients were excluded from the study for the following criteria: poor TTE quality (nϭ7), prior cardiac surgery (nϭ4), and prior septal ethanol ablation (nϭ4), leaving a final study population of 100 patients. Forty-two patients underwent simultaneous measurement of echocardiographic and catheterization parameters. Clinical indications for cardiac catheterization were percutaneous septal ethanol ablation in 55 patients and diagnostic hemodynamic evaluation in 45 other patients. All patients provided informed consent for review of their medical records in accordance with Minnesota law. All authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Invasive Hemodynamic Study
All invasive studies were performed in a fasting state with conscious sedation. Cardioactive medications were continued on the day of the procedure. Femoral venous access was used to gain access to the right heart. LAP was directly measured via transseptal puncture with placement of an 8F Mullins sheath into the left atrium. High-fidelity, micromanometer-tip catheters (Millar Instruments, Houston, Tex) were used in 55 patients as previously described. 14 Fluid-filled catheters were used in the remaining patients. All invasive hemodynamic measurements were acquired at steady state from endexpiratory cycles before septal alcohol ablation or administration of cardiotropic medications. For 92 patients, rapid-acquisition (5-ms intervals) digital records were employed for data collection and subsequent offline analysis. In 8 patients, paper records were digitally scanned, scaled, and analyzed with the use of a set pixel-to-height ratio. The following variables were derived: LAP, left ventricular outflow tract (LVOT) gradient, LV pre-A wave, and left ventricular end-diastolic pressure (LVEDP) (Figure 1 ). In addition, minimum LV pressure, peak ϪdP/dt, and the time constant of relaxation were analyzed in patients who underwent catheterization with high-fidelity, micromanometer-tip catheters (55 patients). The time constant of LV relaxation was calculated by the method of Weiss et al. 15 
Echocardiographic Measurements
All echocardiographic data were averaged from 3 to 5 end-expiratory cycles. LV cavity size, wall thickness, and ejection fraction were measured in accordance with American Society of Echocardiography recommendations. 16 Left atrial volume was measured from 2 orthogonal views as previously described. 17, 18 Mitral inflow velocity curves and annular TDI signals were obtained as previously described 2 ( Figure 1 ). Peak Doppler velocities were analyzed to determine early (E) and late (A) diastolic flow across the mitral valve. Mitral regurgitation was graded as none/trivial, mild, moderate, moderately severe, or severe by combined analysis of jet area, jet width, and spectral Doppler intensity. 19 TDI of the mitral annulus was obtained from the apical 4-chamber view, and peak early tissue Doppler velocities of the medial mitral annulus (medial eЈ) were analyzed. In 42 patients who had simultaneous echocardiographic and catheterization studies, the peak early tissue Doppler velocity of the lateral mitral annulus (lateral eЈ) was also obtained.
Data Analysis
Continuous variables are expressed as meanϮSD. Correlation of continuous variables was examined with simple linear regression analysis. Two-sample Student t tests, 2 analyses, and Fisher exact tests were used as appropriate. Receiver operating characteristic (ROC) curves were generated to assess the correlation of the E-eЈ ratio and mean LAP for mean LAP Ն15 mm Hg and mean LAP Ն20 mm Hg. 20, 21 The area under the curve (AUC) was reported as meanϮSD.
Bland-Altman analysis with 95% confidence limits of agreement was used to compare pressure measurements. 22 performed by Bland-Altman analysis. With the use of the same statistical methodology, separate analysis of the lateral E-eЈ ratio was performed. In addition, a regression equation derived from previously published data in patients without HCM using the medial eЈ velocity was studied 4 ([mean LAP]ϭ0.5762ϫ[E-eЈ ratio]ϩ6.1449). Statistical significance was set a priori at PϽ0.05. Table 1 lists the clinical characteristics of the study population. The mean population age was 58Ϯ13 years. The majority of patients (82%) had moderately severe or severe dyspnea (New York Heart Association class III or IV). Ten percent had moderately severe or severe mitral regurgitation. There were no significant differences in demographic or clinical characteristics between the patients undergoing simultaneous TTE and catheterization studies and the remainder of the population. Table 2 shows hemodynamic data acquired during TTE and cardiac catheterization; there were no significant differences between patients who underwent simultaneous studies and those who did not. Overall, directly measured mean LAP was 17.4Ϯ8.4 mm Hg, with 68 patients (68%) having LAP Ͼ12 mm Hg. LVOT gradients were present at rest (Ն30 mm Hg) in 58 patients and after provocation (Ն50 mm Hg) in 8 others. LVOT gradients were present at rest (Ն30 mm Hg) in 19 patients who underwent simultaneous studies.
Results

Baseline Characteristics
Hemodynamic Data
Bland-Altman analysis of pre-A LV pressure and mean LAP at cardiac catheterization is shown in Figure 2 . The mean difference between pre-A LV pressure and mean LAP was Ϫ1.3Ϯ4.9 mm Hg (95% confidence limits of agreement, Ϯ9.8 mm Hg). Among patients without moderately severe or severe mitral regurgitation, the mean difference was Ϫ0.76Ϯ3.5 mm Hg (95% confidence limits of agreement, Ϯ7.0 mm Hg). Among all patients, the pre-A LV pressure was lower than the mean LAP at higher levels of mean LAP. Patients with moderately severe or severe mitral regurgitation had a higher mean LAP and a larger difference between mean LAP and pre-A LV pressure than those patients with less severe mitral regurgitation.
Relation of Medial E-e Ratio to Invasive Mean LAP
Mean LAP was directly related to the medial E-eЈ ratio in the overall group (rϭ0.44, PϽ0.0001) (Figure 3 ). Mean LAP also was related to medial E-eЈ ratio among patients without History of atrial fibrillation, n (%)
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An ROC curve was constructed to show the sensitivity and specificity of the medial E-eЈ ratio for LAP values of Ն15 mm Hg and Ն20 mm Hg for the overall subgroup ( Figure 4) . The AUC for mean LAP Ն15 mm Hg was 0.74Ϯ0.49. For mean LAP Ն20 mm Hg, the AUC was 0.73Ϯ0.55. For patients with simultaneous studies, the AUCs for mean LAP Ն15 mm Hg and mean LAP Ն20 mm Hg were 0.65Ϯ0.55 and 0.61Ϯ0.67, respectively.
Relation of Invasively and Noninvasively Derived Mean LAP (Medial E-e Ratio)
A Bland-Altman correlation was performed to compare mean LAP measured at catheterization with a calculated LV filling pressure derived from the medial E-eЈ ratio with the use of a previously described regression equation 7 ( Figure 5 ). The mean difference between the calculated LV filling pressure and measured LAP was Ϫ7.3Ϯ9.3 mm Hg (95% confidence limits of agreement, Ϯ18.6 mm Hg). With exclusion of the 10 patients with moderately severe or severe mitral regurgitation, the mean difference was Ϫ7.3Ϯ8.9 mm Hg (95% confidence limits of agreement, Ϯ17.8 mm Hg). For patients with simultaneous TTE and catheterization measurements, Bland-Altman correlation of directly measured mean LAP and calculated LV filling pressure with the use of the medial E-eЈ ratio and a previously reported regression equation is shown. 7 The patients who underwent simultaneous Doppler and catheterization studies are shown in the shaded squares.
the mean difference between the calculated LV filling pressure and measured LAP was Ϫ7.6Ϯ9.8 mm Hg (95% confidence limits of agreement, Ϯ19.6 mm Hg). In addition, LV filling pressure was derived from a regression equation that had previously correlated the medial E-eЈ ratio with LV filling pressure in patients without HCM. 4 With the use of this regression equation, the mean difference between the calculated LV filling pressure and measured LAP was Ϫ0.5Ϯ6.9 mm Hg (95% confidence limits of agreement, Ϯ13.8 mm Hg).
Categorical Medial E-e Ratio
Medial E-eЈ ratios were divided into 3 categories (Ͻ8, 8 to 15, Ͼ15) for comparison with directly measured mean LAP ( Figure 6 ). Only 1 patient was found to have a medial E-eЈ ratio of Ͻ8. Sixty-three patients (63%) had a medial E-eЈ ratio of Ͼ15. Among these patients, the mean LAP was Ͼ20 mm Hg in 28 patients (44%), whereas 17 patients (27%) had a mean LAP Ͻ15 mm Hg.
Comparison of Medial and Lateral e
The lateral eЈ was higher than the medial eЈ (6.8Ϯ2.3 versus 5.3Ϯ1.8 cm/s; PϽ0.001), resulting in lower E-eЈ ratios from the lateral annulus (14.3Ϯ7.0 versus 19.3Ϯ8.5; Pϭ0.02). There was a modest correlation of mean LAP with lateral E-eЈ (rϭ0.31, Pϭ0.05) but no significant correlation between lateral E-eЈ and pre-A LV pressure (rϭ0.07, Pϭ0.64). With the use of lateral eЈ and a previously published regression equation, 7 the mean difference between the measured LAP and calculated LV filling pressure was Ϫ3.1Ϯ9.2 mm Hg (95% confidence limits of agreement, Ϯ18.4 mm Hg). The mean difference between the measured pre-A LV pressure and calculated LV filling pressure was Ϫ3.2Ϯ10.0 mm Hg (95% confidence limits of agreement, Ϯ20.0 mm Hg). ROC analysis of the lateral E-eЈ ratio revealed AUCs for mean LAP Ն15 mm Hg and mean LAP Ն20 mm Hg of 0.73Ϯ0.50 and 0.57Ϯ0.65, respectively. Among the 14 patients with lateral E-eЈ Ͼ15, the pre-A LV pressure was Ͼ20 mm Hg in 4 and Ͻ15 mm Hg in 5.
Discussion
This study compared currently available Doppler-derived diastolic parameters with direct measurements of LAP in patients with HCM, the majority of whom had severe symptoms. There were statistically significant correlations between the Doppler-derived diastolic parameters and invasive measurements. However, the predictive accuracy of the E-eЈ ratio for estimation of mean LAP in an individual patient was modest. When the E-eЈ ratio and a previously published regression equation for derivation of LV filling pressures were used, the 95% confidence limits of agreement exceeded Ϯ18 mm Hg, which is the difference between normal and markedly elevated filling pressures. These observations were evident among all patients as well as those who underwent simultaneous TTE and catheterization studies, indicating that the end result of the complex pathophysiological process of diastolic filling in patients with HCM cannot be assessed reliably by currently used Doppler parameters.
The clinical utility of the E-eЈ ratio for assessment of mean LAP in an individual patient can be seen from the ROC curve depicted in Figure 4 . Transmitral flow velocities depict the relative pressures between the left atrium and the LV and are dependent on LAP, ventricular relaxation, and ventricular suction of the mitral annulus. As such, they provide an overall measure of the rate of ventricular relaxation and suction. Prior studies from our laboratory and others have found clinically useful E-eЈ ratio cutoff values: An E-eЈ ratio Ͻ8 is indicative of normal filling pressures, whereas an E-eЈ ratio Ͼ15 is indicative of markedly elevated filling pressures. 4 However, these same categorical criteria cannot be applied to HCM patients ( Figure 6 ). In our study, only 1 patient had an E-eЈ ratio Ͻ8. This finding is consistent with the severe diastolic abnormalities known to occur in symptomatic patients with HCM and limits the utility of Doppler velocities for determination of LAP in these patients. Furthermore, LAP was Ͻ15 mm Hg in Ϸ25% of patients with an E-eЈ ratio Ͼ15. This observation illustrates the lack of specificity of a high E-eЈ ratio in determining marked elevation of filling pressures. Although the combination of TDI and transmitral velocities has been of clinical utility in determining filling abnormalities in other patient populations, 4 -9,23-26 it is important to recognize their limitations in patients with HCM.
Diastolic dysfunction is found in virtually all patients with HCM 27 and is a critical aspect of the underlying pathophysiology of HCM. Its precise nature and etiology in patients with HCM is complex and may be affected by inactivationdependent processes (myocardial ischemia, intracellular calcium overload), load-dependent processes (myocardial fibrosis, regional asynchrony, and valve state-dependent ventricular wall tension), and atrial hemodynamics. 28 Various methods, including cineangiography, radionuclide angiography, and echocardiography, have been used to evaluate diastolic dysfunction in HCM. 27,29 -37 In these studies, abnormalities of impaired LV relaxation and reduced myocardial compliance have been consistent features present in the vast majority of HCM patients and may be independent of degree of LVOT obstruction and extent of hypertrophy. 28 In the present investigation, the direct measurement of mean LAP was used for LV filling pressure. Prior studies have used surrogates of mean LAP including pulmonary capillary wedge pressure, pre-A LV pressure, and LVEDP. 7, 26 As shown in Figure 2 , there can be a discrepancy between these surrogates and true mean LAP, depending on the compliance of the LV, the height of the V wave, and the relative contribution from atrial contraction. These discrepancies may become greater at higher levels of true LAP and in patients with hemodynamically significant mitral regurgitation. Physiologically, it is the mean LAP that is reflected back into the pulmonary circulation, and this parameter therefore is of greatest importance when the clinical effect of diastolic dysfunction is assessed. Nevertheless, in analyses that utilized pre-A LV pressure, the present study found similar limitations of Doppler parameters in this population of HCM patients.
Prior studies have shown a stronger correlation of filling pressures and Doppler parameters in patients with HCM using the E-eЈ ratio from the lateral annulus. In our institution, we have routinely used the TDI from the medial annulus to assess filling pressures on the basis of the higher reliability and accuracy compared with the lateral annulus found in our prior studies. 4 Because patients with HCM may have dyssynchronous contraction, we prospectively measured the lateral annulus TDI in patients undergoing simultaneous catheterization and compared findings with both pre-A LV pressure and mean LAP. The 95% confidence limits of agreement were large (Ϯ18 mm Hg), with ROC curves similar to those obtained when the medial annulus was used. Thus, precise determination of filling pressure in any individual patient cannot be made whether the medial or lateral annulus is used.
Limitations
The major limitation of this study is the fact that not all echocardiographic studies were performed simultaneously with cardiac catheterization. Loading conditions between an echocardiographic examination and a catheterization performed at a different time may vary and affect the results of a study examining noninvasive evaluation of LV filling pressure. Data are thus presented for the overall population (nϭ100) as well as for the simultaneous subgroup (nϭ42). In the present investigation, there was little difference in the results of the subgroup who had simultaneous measurement of Doppler and invasive data versus the entire study group. In addition, the finding that Doppler parameters do not correlate well with invasive measures of mean LAP at any time, irrespective of the possible change in loading conditions, is of clinical relevance for the evaluation and management of patients with HCM. The clinical implication is that an E-eЈ ratio performed at a specific time does not rule in or rule out an elevated filling pressure as the cause of symptoms in a patient.
The majority of patients were severely symptomatic, and thus this population may not represent the full spectrum of patients presenting with HCM. There was a low Doppler tissue eЈ velocity in the population studied, and only 1 patient had a "normal" E-eЈ ratio of Ͻ8. However, it has been recognized that patients with HCM, even if asymptomatic, do not have normal annular velocities 38 because abnormalities of myocardial relaxation inherent in these patients will lower the eЈ tissue velocity. Similarly, in an analysis of Ͼ2000 echocardiograms performed in outpatients presenting to our HCM clinic, an E-eЈ ratio of Ͻ8 was present in Ͻ7% of all patients, whereas an E-eЈ ratio Ͼ15 was present in Ͼ45%. Thus, the distribution of E-eЈ in this study is similar to that of a large outpatient group of patients presenting with HCM.
Conclusions
Although there is an overall correlation between the E-eЈ ratio and invasively derived LAP, LV filling pressures cannot be derived accurately with the use of the E-eЈ ratio for an individual patient with symptomatic HCM. To accurately assess the diastolic filling properties of patients with HCM, further analysis of measures such as color M-mode echocardiography, left atrial volume, pulmonary venous pressure, and newer myocardial function parameters, including strain and torsion, is warranted.
CLINICAL PERSPECTIVE
Doppler echocardiography has been used increasingly for the noninvasive estimation of ventricular filling pressures. However, relatively few data exist on the utility of these indices in patients with hypertrophic cardiomyopathy (HCM). The present study examined the relation of currently available Doppler parameters to invasively derived left ventricular filling pressures in HCM, including direct measurement of left atrial pressure. One hundred symptomatic HCM patients underwent Doppler assessment and cardiac catheterization within 48 hours, including 42 patients who had simultaneous studies. Mean left atrial pressure was directly related to the medial E-eЈ ratio (rϭ0.44, PϽ0.0001). However, significant scatter was present, and the confidence limits of agreement were Ϯ18.6 mm Hg, which spans the difference between normal and markedly elevated filling pressures. Few patients with HCM had "normal" E-eЈ ratios, and high E-eЈ ratios lacked specificity in identifying severe elevation of left atrial pressure. Thus, although there is a relation between Doppler parameters and invasively measured ventricular filling pressures, precise characterization of these pressures in an individual HCM patient cannot be determined solely with the use of these noninvasive methods.
